Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by GlaxoSmithKline
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01342952
First received: April 26, 2011
Last updated: April 3, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2024
  Estimated Primary Completion Date: December 2022 (Final data collection date for primary outcome measure)